We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CU2 market cap is 318.5M. The company's latest EPS is USD -0.2019 and P/E is -8.82.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 93.77M | 114.25M | 159.52M | 162.05M | 186.8M |
| Operating Income | -66.23M | -58.33M | -48.94M | -62.08M | -30.05M |
| Net Income | -71.24M | -59.86M | -54.37M | -42.78M | -37.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 165.54M | 221.42M | 237.5M | 218.09M | 197.75M |
| Total Liabilities | 108.48M | 117.61M | 151.88M | 149.53M | 144.3M |
| Total Equity | 57.05M | 103.81M | 85.62M | 68.56M | 53.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.84M | -40.74M | -33.92M | -25.62M | -43.17M |
| Investing | 28.19M | -49.56M | 12.69M | 8.46M | 8.62M |
| Financing | 43.49M | 91.78M | 34.29M | 4.19M | 10.67M |
| Market Cap | 318.5M |
| Price to Earnings Ratio | -8.82 |
| Price to Sales Ratio | 1.77 |
| Price to Cash Ratio | 28.39 |
| Price to Book Ratio | 6.19 |
| Dividend Yield | - |
| Shares Outstanding | 185.72M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.08 (4.45%) |
| Company Name | Cerus Corp. |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cerus.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
